European stocks extend gains as Adidas propels DAX to record high

Reuters
22 Jan
European stocks extend gains as Adidas propels DAX to record high

For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window

Jan 22 (Reuters) - European stocks extended their recent run of gains on Wednesday, with strong holiday-quarter performance from Adidas pushing German shares to record highs and healthcare stocks posting strong gains.

The pan-European STOXX 600 .STOXX was up 0.5%, as of 0822 GMT, and trading at its highest level since Sept. 27, 2024.

Heavyweight healthcare stocks .SXDP led the charge, rising 1.1%, boosted by a 2.7% uptick in drugmaker Novo Nordisk NOVOb.CO.

Shares of Adidas ADSGn.DE jumped 6% after the German sportswear brand reported what it said were better-than-expected preliminary fourth-quarter results, with strong sales and profitability for the important holiday shopping period.

Puma PUMG.DE rose 2.5%, while Germany's benchmark index .GDAXI outperformed its regional peers, adding 0.9% to touch a record peak.

The upbeat mood in markets came even as U.S. President Donald Trump pledged to hit the European Union with fresh levies and said his administration was discussing imposing a 10% tariff on goods from China on Feb. 1.

In other stocks, Schaeffler SHA0.DE tumbled 15% after the German automotive supplier reported lower-than-expected preliminary results for 2024.

(Reporting by Nikhil Sharma in Bengaluru; Editing by Sherry Jacob-Phillips)

((Nikhil.Sharma@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10